Bluesky Facebook Reddit Email

Enzyme may represent new target for treating asthma

05.20.19 | American Thoracic Society

GoPro HERO13 Black

GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.


ATS 2019, Dallas, TX -- An enzyme called diacylglycerol kinase zeta (DGKζ) appears to play an important role in suppressing runaway inflammation in asthma and may represent a novel therapeutic target, according to research presented at ATS 2019. The researchers deleted the enzyme in mouse T cells, which drive the immune system, and found that both inflammation and airway hyper-responsiveness, two hallmarks of asthma, were reduced through independent biomolecular mechanisms.

###

VIEW ABSTRACT

Session: B29 Mechanisms for Airway Hyperresponsiveness: From Cell to Organism
Abstract Presentation Time: Monday, May 20, 9:15 a.m. CT
Location: Ballroom D Four (Level 3), Kay Bailey Hutchison Convention Center Dallas

Keywords

Contact Information

How to Cite This Article

APA:
American Thoracic Society. (2019, May 20). Enzyme may represent new target for treating asthma. Brightsurf News. https://www.brightsurf.com/news/8OJ5K3E1/enzyme-may-represent-new-target-for-treating-asthma.html
MLA:
"Enzyme may represent new target for treating asthma." Brightsurf News, May. 20 2019, https://www.brightsurf.com/news/8OJ5K3E1/enzyme-may-represent-new-target-for-treating-asthma.html.